Weiwei Chu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Reproductive Medicine top 5%
- Ovarian function and disorders
Papers in
-
- Muscle Physiology and Disorders 4
- Circular RNAs in diseases 4
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 8
- Co-authors
- Yanzhi Du (13 shared papers)Zi‐Jiang Chen (12 shared papers)Shang Li (11 shared papers)Xiaojian Zhao (9 shared papers)Yaxiao Zhang (9 shared papers)Baolei Lv (9 shared papers)Renfeng Wang (8 shared papers)Qiang Zhen (8 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Gene (2 papers)Scientific Reports (2 papers)Cell Proliferation (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Weiwei Chu
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 423
- Reproductive Medicine 158
- Molecular Biology 605
- Urology 43
- Endocrine and Autonomic Systems 46
Countries citing papers authored by Weiwei Chu
This map shows the geographic impact of Weiwei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Chu more than expected).
Fields of papers citing papers by Weiwei Chu
This network shows the impact of papers produced by Weiwei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Chu. The network helps show where Weiwei Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 98 | |
| 2 | 2020 | 88 | |
| 3 | 2020 | 78 | |
| 4 | 2017 | 77 | |
| 5 | 2015 | 56 | |
| 6 | 2020 | 52 | |
| 7 | 2020 | 51 | |
| 8 | 2018 | 35 | |
| 9 | 2024 | 35 | |
| 10 | 2020 | 34 | |
| 11 | 2021 | 31 | |
| 12 | 2020 | 29 | |
| 13 | 2015 | 29 | |
| 14 | 2017 | 27 | |
| 15 | 2024 | 24 | |
| 16 | 2019 | 24 | |
| 17 | 2019 | 24 | |
| 18 | 2023 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2022 | 21 |
About Weiwei Chu
Weiwei Chu is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Surgery and Rehabilitation, having authored 72 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers), Hair Growth and Disorders (5 papers), Ovarian function and disorders (5 papers), Adipose Tissue and Metabolism (4 papers), Muscle Physiology and Disorders (4 papers), Circular RNAs in diseases (4 papers) and Circadian rhythm and melatonin (4 papers). The work is most often cited by research in Cancer Research (423 citations), Reproductive Medicine (158 citations), Molecular Biology (605 citations), Urology (43 citations) and Endocrine and Autonomic Systems (46 citations). Weiwei Chu has collaborated with scholars based in China, United States and France. Frequent co-authors include Yanzhi Du, Zi‐Jiang Chen, Shang Li, Xiaojian Zhao, Yaxiao Zhang, Baolei Lv, Renfeng Wang, Qiang Zhen, Junyu Zhai and Jia‐Bao Liu. Their work appears in journals such as Frontiers in Oncology, Gene, Scientific Reports, Cell Proliferation and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.